335 related articles for article (PubMed ID: 30327855)
1. Use of
Manabe O; Ohira H; Hirata K; Hayashi S; Naya M; Tsujino I; Aikawa T; Koyanagawa K; Oyama-Manabe N; Tomiyama Y; Magota K; Yoshinaga K; Tamaki N
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1240-1247. PubMed ID: 30327855
[TBL] [Abstract][Full Text] [Related]
2. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
3. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Lu Y; Grant C; Xie K; Sweiss NJ
Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
[TBL] [Abstract][Full Text] [Related]
7. Inter- and Intraobserver Agreement of
Ohira H; Ardle BM; deKemp RA; Nery P; Juneau D; Renaud JM; Klein R; Clarkin O; MacDonald K; Leung E; Nair G; Beanlands R; Birnie D
J Nucl Med; 2017 Aug; 58(8):1324-1329. PubMed ID: 28254873
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
9. Texture analysis of delayed contrast-enhanced computed tomography to diagnose cardiac sarcoidosis.
Tsuneta S; Oyama-Manabe N; Hirata K; Harada T; Aikawa T; Manabe O; Ohira H; Koyanagawa K; Naya M; Kudo K
Jpn J Radiol; 2021 May; 39(5):442-450. PubMed ID: 33483941
[TBL] [Abstract][Full Text] [Related]
10. Beads phantom for evaluating heterogeneity of SUV on
Okuda K; Saito H; Yamashita S; Yamamoto H; Ichikawa H; Kato T; Yokoyama K; Doai M; Hashimoto M; Matoba M
Ann Nucl Med; 2022 May; 36(5):495-503. PubMed ID: 35377093
[TBL] [Abstract][Full Text] [Related]
11. Textural features of
Saleem BR; Beukinga RJ; Boellaard R; Glaudemans AW; Reijnen MM; Zeebregts CJ; Slart RH
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):886-894. PubMed ID: 28013350
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.
Manabe O; Takahashi K; Kawakami H; Ohtsuka A; Aikawa T; Maki H; Ibe T; Fujita H; Oyama-Manabe N
Ann Nucl Med; 2023 Oct; 37(10):535-540. PubMed ID: 37418117
[TBL] [Abstract][Full Text] [Related]
14. Unenhanced CT texture analysis with machine learning for differentiating between nasopharyngeal cancer and nasopharyngeal malignant lymphoma.
Tomita H; Yamashiro T; Iida G; Tsubakimoto M; Mimura H; Murayama S
Nagoya J Med Sci; 2021 Feb; 83(1):135-149. PubMed ID: 33727745
[TBL] [Abstract][Full Text] [Related]
15. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
[TBL] [Abstract][Full Text] [Related]
16. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
18. Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
Yoon HJ; Kim Y; Chung J; Kim BS
Breast J; 2019 May; 25(3):373-380. PubMed ID: 29602210
[TBL] [Abstract][Full Text] [Related]
19. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
20. Robustness of [
Palomino-Fernández D; Seiffert AP; Gómez-Grande A; Jiménez López-Guarch C; Moreno G; Bueno H; Gómez EJ; Sánchez-González P
Comput Methods Programs Biomed; 2024 Feb; 244():107981. PubMed ID: 38154326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]